Potential COVID-19 vaccine in the works from UW-Madison, partners

Posted at 10:49 AM, Apr 03, 2020
and last updated 2020-04-03 11:49:43-04

MADISON — A collaboration between the University of Wisconsin–Madison and vaccine companies could yield a potential COVID-19 vaccine by the end of the year.

FluGen, Bharat Biotech, along with UW-Madison virologists, has begun the development and testing of a vaccine against COVID-19 called CoroFlu.

Developing and testing will take at least three to six months.

CoroFlu could be in human clinical trials by the fall of 2020.

Bharat Biotech has commercialized 16 vaccines, including a vaccine developed against the H1N1 flu that caused the 2009 H1N1 pandemic.

“The partners in this endeavor, University of Wisconsin researchers, a biotech startup, and an international vaccine developer, are moving forward with a sense of urgency and integrity incumbent upon us as scientists and world citizens.” says Erik Iverson, CEO of WARF (Wisconsin Alumni Research Foundation) in a press release.

To learn more, click here.

Report a typo or error // Submit a news tip

Coronavirus in Wisconsin

More data on Wisconsin's vaccination progress here.

Find a vaccination site here.

Check out county-by-county coronavirus case numbers here.

More information: COVID-19 on the Wisconsin DHS website

Latest news and headlines here.